ArticleInternational journal of retina and vitreous2025

Real-world short-term outcomes after switching to fixed-interval anti-VEGF therapy for neovascular AMD during the COVID-19 pandemic.

Arnulfo Garza Reyes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.